Overview
HeartFlow is a leader in precision heart care, utilizing a proprietary AI-powered platform to transform standard Coronary Computed Tomography Angiography (CCTA) scans into personalized 3D models of the heart's arteries. The core technology, the HeartFlow FFRct Analysis, applies advanced Computational Fluid Dynamics (CFD) and deep learning algorithms to simulate blood flow and calculate Fractional Flow Reserve (FFR) values non-invasively. By 2026, HeartFlow has expanded its suite to include comprehensive Plaque Analysis and RoadMap vessel guidance, positioning itself as the central intelligence layer for 'CT-first' cardiac care strategies. The architecture operates on a secure cloud-based model where DICOM data is uploaded, processed by AI models trained on millions of data points, and validated by expert analysts. This process effectively reduces the rate of unnecessary invasive coronary angiograms by providing clinicians with both anatomical and functional insights into coronary artery disease (CAD). The platform is deeply integrated into hospital PACS systems and complies with global medical standards, including FDA 510(k) clearances and CE marking, ensuring high-fidelity diagnostic accuracy for complex clinical decision-making.